| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Net income | |||||||||
1,927 | 2,272 | 2,151 | 1,436 | 948 | 409 | -1 | 0 | 0 | 0 |
Adjustments to reconcile net income to net cash used in operating activities: | |||||||||
Income earned on investment held in Trust Account | |||||||||
3,234 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Changes in operating assets and liabilities: | |||||||||
Prepaid expenses and other current assets | |||||||||
24 | 0 | 0 | 0 | - | - | - | - | - | - |
Prepaid expenses | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Accounts payable and accrued expenses | |||||||||
44 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Franchise tax payable | |||||||||
13 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Income tax payable | |||||||||
-306 | 0 | 0 | 0 | - | - | - | - | - | 0 |
Net cash used in operating activities | |||||||||
-1,579 | -1,308 | -1,119 | -458 | -237 | -145 | -1 | 0 | 0 | 0 |
Cash flow from investing activities | |||||||||
Cash deposited in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by (used in) investing activities | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Cash flows from financing activities | |||||||||
Proceeds from sale of shares of common stock to initial stockholder | |||||||||
- | - | - | - | - | - | - | - | 0 | 0 |
Proceeds from note payable- related party | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Repayment of note payable- related party | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Payment of offering costs associated with initial public offering | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Proceeds from sale of private units | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | |||||||||
- | - | - | - | 150,142 | 150,134 | 9 | 0 | 0 | 0 |
Net increase (decrease) in cash | |||||||||
-320 | -197 | 384 | 159 | 404 | 488 | 8 | 0 | 0 | 0 |
Supplemental disclosure of non-cash financing activities: | |||||||||
Initial classification of common stock subject to possible redemption | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Deferred underwriting commissions charged to additional paid-in-capital in connection with the initial public offering | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Offering costs paid by initial stockholder in exchange for common stock | |||||||||
- | - | - | - | - | - | - | - | 0 | 0 |
Accrued formation and offering costs | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Change in value of common stock subject to possible redemption | |||||||||
1,927 | 0 | 0 | 0 | - | - | - | - | - | - |